share_log

康方生物-B:自願公告 - 依沃西(PD-1 /VEGF,AK112)聯合佐斯利單抗(CD73,AK119)治療晚期實體瘤Ib / II期臨床試驗獲批開展

AKESO, INC. - B: VOLUNTARY ANNOUNCEMENT - APPROVAL OF COMMENCEMENT OF PHASE IB/II CLINICAL TRIAL OF IVONESCIMAB (PD-1/VEGF, AK112) COMBINED WITH DREBUXELIMAB (CD73, AK119) FOR THE TREATMENT OF ADVANCED SOLID TUMORS

Oct 14, 2022 05:37
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more